The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy
- PMID: 7813013
- DOI: 10.1016/0092-8674(95)90461-1
The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy
Abstract
The spinal muscular atrophies (SMAs), characterized by spinal cord motor neuron depletion, are among the most common autosomal recessive disorders. One model of SMA pathogenesis invokes an inappropriate persistence of normally occurring motor neuron apoptosis. Consistent with this hypothesis, the novel gene for neuronal apoptosis inhibitory protein (NAIP) has been mapped to the SMA region of chromosome 5q13.1 and is homologous with baculoviral apoptosis inhibitor proteins. The two first coding exons of this gene are deleted in approximately 67% of type I SMA chromosomes compared with 2% of non-SMA chromosomes. Furthermore, RT-PCR analysis reveals internally deleted and mutated forms of the NAIP transcript in type I SMA individuals and not in unaffected individuals. These findings suggest that mutations in the NAIP locus may lead to a failure of a normally occurring inhibition of motor neuron apoptosis resulting in or contributing to the SMA phenotype.
Comment in
-
Genes for SMA: multum in parvo.Cell. 1995 Jan 13;80(1):1-5. doi: 10.1016/0092-8674(95)90442-5. Cell. 1995. PMID: 7813005 Review. No abstract available.
Similar articles
-
Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.Hum Mol Genet. 1995 Oct;4(10):1927-33. doi: 10.1093/hmg/4.10.1927. Hum Mol Genet. 1995. PMID: 8595417
-
Sequence of a 131-kb region of 5q13.1 containing the spinal muscular atrophy candidate genes SMN and NAIP.Genomics. 1998 Feb 15;48(1):121-7. doi: 10.1006/geno.1997.5141. Genomics. 1998. PMID: 9503025
-
Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype.Hum Mol Genet. 1996 Feb;5(2):257-63. doi: 10.1093/hmg/5.2.257. Hum Mol Genet. 1996. PMID: 8824882
-
[Molecular genetic diagnosis and deletion analysis in Type I-III spinal muscular atrophy].Schweiz Med Wochenschr. 1996 May 25;126(21):907-14. Schweiz Med Wochenschr. 1996. PMID: 8693311 Review. German.
-
Genes for SMA: multum in parvo.Cell. 1995 Jan 13;80(1):1-5. doi: 10.1016/0092-8674(95)90442-5. Cell. 1995. PMID: 7813005 Review. No abstract available.
Cited by
-
Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms.J Biol Chem. 2001 Jun 1;276(22):18702-9. doi: 10.1074/jbc.M011774200. Epub 2001 Mar 12. J Biol Chem. 2001. PMID: 11278985 Free PMC article.
-
The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7.J Neurosci. 2002 Mar 15;22(6):2035-43. doi: 10.1523/JNEUROSCI.22-06-02035.2002. J Neurosci. 2002. PMID: 11896143 Free PMC article.
-
Spinal muscular atrophy.Curr Neurol Neurosci Rep. 2004 Jan;4(1):74-80. doi: 10.1007/s11910-004-0016-6. Curr Neurol Neurosci Rep. 2004. PMID: 14683633 Review.
-
Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy.Skelet Muscle. 2019 May 24;9(1):13. doi: 10.1186/s13395-019-0201-6. Skelet Muscle. 2019. PMID: 31126323 Free PMC article.
-
IAP proteins as targets for drug development in oncology.Onco Targets Ther. 2013 Sep 16;9:1285-304. doi: 10.2147/OTT.S33375. Onco Targets Ther. 2013. PMID: 24092992 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
